Then, in our in vivo model, we demonstrated that low doses of Dox in combination with MSC/GM-CSF increased the number of macrophages (F4/80+), the number of cytotoxic T cells (CD3+/CD8+) and the levels of proinflammatory cytokines within the tumour. The gene discussed is CD8A; the disease is neoplasm.